Ludwig Fund Gives $120 Million for Cancer Research
Memorial Sloan-Kettering Cancer Center is one of six leading institutions that will share in a $120 million gift from a foundation created by American billionaire Daniel K. Ludwig. The gift will allow Memorial Sloan-Kettering to accelerate the pace at which the findings of basic scientific studies are moved into translational work with clinical applications.
Survivorship Celebrated at Memorial Sloan-Kettering Cancer Center
Hundreds of patients and their families filled the Rockefeller Research Laboratories Auditorium for a program marking National Survivorship Day.
New Approach for Treating Gastrointestinal Stromal Tumors Identified
Memorial Sloan-Kettering researchers report that flavopiridol -- a natural product-based compound being investigated as a cancer drug -- represents a possible new treatment for gastrointestinal stromal tumor (GIST), the most common sarcoma of the gastrointestinal tract. Because these tumors sometimes develop resistance to the current standard treatment, imatinib (Gleevec), novel therapies are needed.
Red Blood Cells Deliver Protein Systemically
Memorial Sloan-Kettering researchers have demonstrated in mice that red blood cell precursors derived from bone marrow stem cells could be engineered to produce a secreted protein at therapeutic levels over a prolonged period. This strategy may theoretically be safer than current stem cell-based gene therapies, in which inserted genes are activated in all stem cell-derived cells, increasing the risk of undesirable mutations.
Pediatric Patient Story - Nate Goldstein
Life as they knew it changed for the Goldstein family the day five-year-old Nate was diagnosed with an advanced sarcoma in his leg. Every doctor they met gave him little chance of surviving, with amputation of his entire leg the only treatment choice. Every doctor, that is, until they met Memorial Sloan-Kettering's Leonard Wexler, who accepted neither the survival statistics nor the necessity of removing Nate's leg.
Make a Gift
Today, thanks to the efforts of such institutions as Memorial Sloan-Kettering Cancer Center, about half of those diagnosed with cancer will have their disease brought under control, and many will be cured. Every successful step we make in cancer research today could very well benefit you -- or someone you love -- tomorrow. Make a gift to support our programs of patient care, research, and education.
65+ Educational Lecture Series
Sponsored by the Post-Treatment Resource Program, this lecture series discusses topics of interest to older adults who have been treated for cancer.
WWW Gateway -- Cancer-Related Information Resources
To help cancer patients and their families find the best, most reliable cancer-related online resources, Memorial Sloan-Kettering has created its WWW Gateway -- Cancer-Related Resources on Other Web Sites.
